ºÝºÝߣ

regulatory vcls healthcare pharmaceutical brexit registration medical devices drug eu medtech biotechnology development usa atmp market access richard dennett outsourcing technology transfer product development potency assay optimization approval launch jean-hugues trouvin valérie pimpaneau françois gianelli anne dupraz poiseau diseases rare strategy medicaldevice expedited programs drug development fda healthtech regulatory science medical device voisin consulting microbiome regulatory strategy clinical in vitro diagnostics clinical trials gene therapy medical framework odd orphan designation status raps hta europe early dialogue health technology assessment